These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 10753948)
21. Cell signalling of glucagon-like peptide-1 action in rat skeletal muscle. Acitores A; González N; Sancho V; Valverde I; Villanueva-Peñacarrillo ML J Endocrinol; 2004 Mar; 180(3):389-98. PubMed ID: 15012593 [TBL] [Abstract][Full Text] [Related]
22. High leptin levels acutely inhibit insulin-stimulated glucose uptake without affecting glucose transporter 4 translocation in l6 rat skeletal muscle cells. Sweeney G; Keen J; Somwar R; Konrad D; Garg R; Klip A Endocrinology; 2001 Nov; 142(11):4806-12. PubMed ID: 11606447 [TBL] [Abstract][Full Text] [Related]
23. Cyclic nucleotide phosphodiesterase 3B is a downstream target of protein kinase B and may be involved in regulation of effects of protein kinase B on thymidine incorporation in FDCP2 cells. Ahmad F; Cong LN; Stenson Holst L; Wang LM; Rahn Landstrom T; Pierce JH; Quon MJ; Degerman E; Manganiello VC J Immunol; 2000 May; 164(9):4678-88. PubMed ID: 10779773 [TBL] [Abstract][Full Text] [Related]
24. Insulin and heregulin-beta1 upregulate guanylyl cyclase C expression in rat hepatocytes: reversal by phosphodiesterase-3 inhibition. Scheving LA; Russell WE Cell Signal; 2001 Sep; 13(9):665-72. PubMed ID: 11495724 [TBL] [Abstract][Full Text] [Related]
25. HIV-1 Tat protein down-regulates CREB transcription factor expression in PC12 neuronal cells through a phosphatidylinositol 3-kinase/AKT/cyclic nucleoside phosphodiesterase pathway. Zauli G; Milani D; Mirandola P; Mazzoni M; Secchiero P; Miscia S; Capitani S FASEB J; 2001 Feb; 15(2):483-91. PubMed ID: 11156964 [TBL] [Abstract][Full Text] [Related]
26. Leptin-mediated activation of human platelets: involvement of a leptin receptor and phosphodiesterase 3A-containing cellular signaling complex. Elbatarny HS; Maurice DH Am J Physiol Endocrinol Metab; 2005 Oct; 289(4):E695-702. PubMed ID: 15886225 [TBL] [Abstract][Full Text] [Related]
27. Combined effects of insulin and dexamethasone on cyclic AMP phosphodiesterase 3 and glycogen metabolism in cultured rat hepatocytes. Hermsdorf T; Dettmer D Cell Signal; 1998 Oct; 10(9):629-35. PubMed ID: 9794244 [TBL] [Abstract][Full Text] [Related]
30. Phosphorylation of PDE3B by phosphatidylinositol 3-kinase associated with the insulin receptor. Rondinone CM; Carvalho E; Rahn T; Manganiello VC; Degerman E; Smith UP J Biol Chem; 2000 Apr; 275(14):10093-8. PubMed ID: 10744689 [TBL] [Abstract][Full Text] [Related]
31. IL-3 and IL-4 activate cyclic nucleotide phosphodiesterases 3 (PDE3) and 4 (PDE4) by different mechanisms in FDCP2 myeloid cells. Ahmad F; Gao G; Wang LM; Landstrom TR; Degerman E; Pierce JH; Manganiello VC J Immunol; 1999 Apr; 162(8):4864-75. PubMed ID: 10202031 [TBL] [Abstract][Full Text] [Related]
32. The use of selective inhibitors and computer modelling to evaluate the role of specific high affinity cyclic AMP phosphodiesterases in the hormonal regulation of hepatocyte intracellular cyclic AMP concentrations. Houslay MD Cell Signal; 1990; 2(1):85-98. PubMed ID: 2176803 [TBL] [Abstract][Full Text] [Related]
33. Role of the PI3K/PKB signaling pathway in cAMP-mediated translocation of rat liver Ntcp. Webster CR; Anwer MS Am J Physiol; 1999 Dec; 277(6):G1165-72. PubMed ID: 10600813 [TBL] [Abstract][Full Text] [Related]
34. An assessment of the ability of insulin-stimulated cyclic AMP phosphodiesterase to decrease hepatocyte intracellular cyclic AMP concentrations. Heyworth CM; Wallace AV; Wilson SR; Houslay MD Biochem J; 1984 Aug; 222(1):183-7. PubMed ID: 6089756 [TBL] [Abstract][Full Text] [Related]